110 related articles for article (PubMed ID: 1968950)
21. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
van Giezen JJ; Minkema J; Bouma BN; Jansen JW
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
[TBL] [Abstract][Full Text] [Related]
22. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
Shainoff JR; Urbanic DA; DiBello PM
J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
[TBL] [Abstract][Full Text] [Related]
23. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
Matsuka YV; Medved LV; Migliorini MM; Ingham KC
Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
Shainoff JR; Stearns DJ; DiBello PM; Hishikawa-Itoh Y
Thromb Haemost; 1990 Apr; 63(2):193-203. PubMed ID: 2163552
[TBL] [Abstract][Full Text] [Related]
25. [Nature of fibrinogen B-soluble fibrin monomer complexes precipitable by ethanol and 2-naphthol].
Zubairov DM; Litvinov RI
Biokhimiia; 1980 Jun; 45(6):1059-67. PubMed ID: 7213845
[TBL] [Abstract][Full Text] [Related]
26. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking.
Weiss E; Yamaguchi Y; Falabella A; Crane S; Tokuda Y; Falanga V
J Cell Physiol; 1998 Jan; 174(1):58-65. PubMed ID: 9397156
[TBL] [Abstract][Full Text] [Related]
27. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
[TBL] [Abstract][Full Text] [Related]
28. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
29. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
von Hugo R; Stemberger A; Graeff H
Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
[TBL] [Abstract][Full Text] [Related]
30. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
Schense JC; Hubbell JA
Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
[TBL] [Abstract][Full Text] [Related]
31. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
Sakata Y; Aoki N
J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue.
Coyne CP; Smith JE; DeBowes RM
Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954
[TBL] [Abstract][Full Text] [Related]
33. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
Siebenlist KR; Meh DA; Mosesson MW
Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
[TBL] [Abstract][Full Text] [Related]
34. The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexes.
Gurewich V; Lipinski B; Hyde E
Thromb Haemost; 1976 Dec; 36(3):605-14. PubMed ID: 1037154
[TBL] [Abstract][Full Text] [Related]
35. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
Kanaide H; Shainoff JR
J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
[TBL] [Abstract][Full Text] [Related]
36. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard.
Puszkin EG; Raghuraman V
J Biol Chem; 1985 Dec; 260(29):16012-20. PubMed ID: 2866189
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of the fibrin intermediate arising from cleavage of one fibrinopeptide A from fibrinogen.
Shainoff JR; Smejkal GB; DiBello PM; Mitkevich OV; Levy PJ; Dempfle CE; Lill H
J Biol Chem; 1996 Sep; 271(39):24129-37. PubMed ID: 8798652
[TBL] [Abstract][Full Text] [Related]
38. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
Galanakis DK; Ghebrehiwet B
J Clin Invest; 1994 Jan; 93(1):303-10. PubMed ID: 8282801
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of aggregation of fibrinogen molecules: the influence of fibrin-stabilising factor.
Rozenfel'd MA; Vasil'eva MV
Biomed Sci; 1991; 2(2):155-61. PubMed ID: 1685332
[TBL] [Abstract][Full Text] [Related]
40. [The shape of fibrin-monomer molecules in solution].
Wiltzius P; Hofmann V
Schweiz Med Wochenschr; 1979 Sep; 109(37):1392. PubMed ID: 39337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
